…clinical studies of hormonal contraception to demonstrate efficacy. Androgen | Conducting clinical trials in obese and older men with outcomes including anthropometry, cardiovascular and diabetes risk, sexual function, and quality…… Read more
…how early life events may lead to life-long diseases such as multiple sclerosis, schizophrenia, chronic lung diseases, obesity, hypertension and diabetes. + Read more Diseases we research Birth asphyxia Cerebral…… Read more
…TLRs are implicated not only in infectious diseases, but also a broad range of chronic inflammatory and autoimmune diseases such as atherosclerosis, asthma, lupus, diabetes, arthritis and cancer. A/Prof Mansell…… Read more
…infection. Dysfunctional responses by NLR family members have been associated with a range of conditions, including inflammatory bowel disease, arthritis, diabetes and various cancers. We are currently investigating the roles…… Read more
Mr Nikshay Karthigan is a member of the Endocrine Hypertension Research Group at Hudson Institute and PhD candidate in the Cardiovascular Endocrinology laboratory at the Baker Heart and Diabetes Institute….… Read more
…as rheumatoid arthritis, type 2 diabetes and cancer. The Lawlor group utilise a range of cellular and molecular biology methods and preclinical disease models. + Read more Diseases we research…… Read more
…D, Armitage JA, Wallace EM, Bertram JF, Cullen-McEwen LA (2019) Normal foetal kidney volume in offspring of women treated for gestational diabetes. Endocrinol Diabetes Metab 2:e00091. Hooper SB, Roberts C,…… Read more
…requirements in women with type 1 diabetes treated with continuous subcutaneous insulin infusion and multiple daily injections: cohort study. Diabetes Technol Ther 19:280-287. Ahmed AU, Yim HCH, Alorro M, Ernst…… Read more
…Pathway in Obesity And Diabetes. FEBS J. Thomas BJ, Kan OK, Loveland K, Elias JA, Bardin PG. (2016) In the Shadow of Fibrosis: Innate Immune Suppression Mediated by Transforming Growth…… Read more
Hudson Institute researchers have shown for the first time that a diabetes drug called sitagliptin can limit tumour growth, and possibly extend survival rates from epithelial ovarian cancer, the most…… Read more
